Determinants of COVID-19 disease severity in patients with underlying rheumatic disease CS Santos, CM Morales, ED Álvarez, CÁ Castro, AL Robles, TP Sandoval Clinical rheumatology 39, 2789-2796, 2020 | 112 | 2020 |
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe? CS Santos, XC Férnandez, CM Morales, ED Álvarez, CÁ Castro, ... RMD open 7 (1), e001439, 2021 | 48 | 2021 |
Immune responses to mRNA vaccines against SARS-CoV2 in patients with immune-mediated inflammatory rheumatic diseases CS Santos RMD Open 8, 1-8, 2022 | 42 | 2022 |
Polyautoimmunität bei systemischem Lupus erythematosus: sekundäres Sjögren-Syndrom C Sieiro Santos, C Moriano Morales, C Álvarez Castro, E Díez Alvarez Zeitschrift für Rheumatologie, 1-6, 2023 | 16 | 2023 |
Post-coronavirus disease syndrome and disseminated microthrombosis: the role of the von Willebrand factor and antiphospholipid antibodies CS Santos, JL Castro Clinics 76 (2784), 2021 | 13 | 2021 |
Anti-TNF-α-induced lupus syndrome: two case reports and review of current literature EDÁ C. Álvarez Castro, C. Moriano Morales Zeitschrift fur Rheumatologie, 1-6, 2021 | 11* | 2021 |
Risk factors for cardiovascular disease in primary Sjögren’s syndrome (pSS): A 20-year follow-up study CS Santos, RR Salgueiro, CM Morales, CÁ Castro, ED Álvarez Clinical Rheumatology 42 (11), 3021-3031, 2023 | 6 | 2023 |
Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2 C Sieiro Santos, C Nogal Arias, C Moriano Morales, M Ballesteros Pomar, ... Clinical Rheumatology 39, 2105-2106, 2020 | 6 | 2020 |
Factors associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus C Sieiro Santos, C Moriano Morales, C Álvarez Castro, ... Musculoskeletal Care 20 (4), 917-925, 2022 | 2 | 2022 |
Refractory Behçet’s Disease with Multi-organ Involvement-Learning from Failure CS Santos, CM Morales, ED Álvarez, TP Sandoval Current Rheumatology Reviews 17 (3), 360-364, 2021 | 2 | 2021 |
Antiphospholipid antibodies in patients with COVID-19 CS Santos Viral Outbreaks, 2020 | 1 | 2020 |
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe? CS Santos, XC Fernandez, CM Morales, EA Diez, CA Castro, AL Robles, ... | 1 | 2020 |
Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk EDÁ Cristiana Sieiro Santos, Maria Miguel Oliveira, Paulo Ney Solari, Pedro ... Reumatología Clinica, 2024 | | 2024 |
POS0461 IMMUNE RESPONSES TO HERPES ZOSTER VACCINE RESPONSES IN RHEUMATIC PATIENTS ON JAK INHIBITORS: INSIGHTS IN HUMORAL AND CELLULAR RESPONSE CS Santos, JO Martínez, ER Martín, XC Fernández, CÁ Castro, AL Robles, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1126-1127, 2024 | | 2024 |
AB1220 BEHIND THE BRONCHIECTASIS IN SYSTEMIC SCLEROSIS. PREVALENCE AND RISK FACTORS M Retuerto-Guerrero, C Moriano, CS Santos, I González, IG Fernández, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1949-1949, 2024 | | 2024 |
AB0224 USE OF JAK INHIBITORS IN REAL CLINICAL PRACTICE: SAFETY ANALYSIS IN A THIRD LEVEL HOSPITAL I González, IG Fernández, PB González, C Díez, M Retuerto-Guerrero, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1350-1350, 2024 | | 2024 |
POS0363 CHALLENGES IN RECOGNIZING VEXAS SYNDROME: DELAYED DIAGNOSIS, MISDIAGNOSIS, AND SPECIFIC GENE MUTATIONS ASSOCIATIONS P García, MLI Gómez, ML Maraver, AG Dorta, BPM López, FJTS de Miera, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 356-356, 2024 | | 2024 |
AB1483 NINTEDANIB IN PROGRESSIVE PULMONARY FIBROSIS. COMPARING SUBGROUPS IN CLINICAL PRACTICE. EXPERIENCE OF PULMONOLOGISTS AND RHEUMATOLOGISTS P Pérez-García, M Retuerto-Guerrero, Y Chuquimia, LS Herránz, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 2108-2109, 2024 | | 2024 |
POS0831 PREDICTIVE SIGNIFICANCE OF BIOMARKERS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: INSIGHTS INTO PROGRESSION, LUNG VOLUME CHANGES, AND MORTALITY RISK M Retuerto-Guerrero, CS Santos, LS Herránz, SC Antolín, EB de Miguel, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1034-1035, 2024 | | 2024 |
AB0038 “RHEUMATOLOGIC” CLINICAL PROFILE OF VEXAS SYNDROME: RESULTS FROM A MULTI-INSTITUTIONAL SPANISH SURVEY JC Alén, MLI Gómez, P García, M López-Maraver, BPM López, J Font, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1245-1245, 2024 | | 2024 |